CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma.
about
Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma.Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form.Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.Beclin 1 deficiency correlated with lymph node metastasis, predicts a distinct outcome in intrahepatic and extrahepatic cholangiocarcinoma.Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinomaCancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs.Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma.ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study.Significance of CD133 expression in esophageal squamous cell carcinoma.Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models.DLL4 overexpression increases gastric cancer stem/progenitor cell self-renewal ability and correlates with poor clinical outcome via Notch-1 signaling pathway activationNovel therapeutic target for cancer stem cells in hepatocellular carcinoma.Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis.The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (Review).Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Clinical implications of microRNAs in liver cancer stem cells.Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome.Downregulated expression of PHLDA1 protein is associated with a malignant phenotype of cholangiocarcinoma.Patients with CD133-negative colorectal liver metastasis have a poor prognosis after hepatectomy.Decreased expression of stem cell markers by simvastatin in 7,12-dimethylbenz(a)anthracene (DMBA)-induced breast cancer.CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma.Cytoplasmic CD133 expression correlates with histologic differentiation and is a significant prognostic factor in extrahepatic bile duct cancer and gallbladder cancer
P2860
Q33574875-1252F59E-49C0-4864-8096-50B4EA2C1C27Q33654429-2234CCF4-7B04-41A1-837B-0F53CF14D699Q33728631-0CEAD967-C662-4705-ACD3-256A667D4550Q34484134-1656A80A-C28D-4EBD-991F-46A930D5C813Q34895116-672C3CA6-7F87-46D2-97B4-C519BAB772A9Q34975197-8B7FA602-5539-4A92-A6B3-A75274B3D773Q35058487-AC7D057B-ED53-4E31-8330-D4F96108CFCBQ35144899-6CA8173E-BC26-489F-9ED6-948AFCE26D21Q35280672-6F72BEDC-F962-443B-8E09-FE31B9EBAF5FQ36046443-E56AA589-C316-4EA0-A307-D59BB3BB9739Q36413028-035609C4-5617-4A3E-B95F-888991E7BE90Q36416575-7C9930D4-E319-4E67-8625-CD712E496E47Q36690373-3246B4C8-064F-492E-9480-553904975C63Q37565162-AEB130E1-A5F6-441F-9943-5B7CB0B6CEACQ37609471-053AD2B9-FEF4-422F-A4B5-39B6CD4213FFQ38034616-7645B32A-FF2B-4E77-9613-7E00CFAFBD0EQ38148062-690AD7AD-78B6-49B5-B2BE-F8A20F76FFC5Q38185910-5AE7B8E6-C63C-490D-B43B-7666E0CF1348Q38584340-5FF4648B-3E32-439B-BC78-3CBC15529F3DQ38720813-35BEF0A5-FB71-490D-A7F2-A63108325531Q39419867-2ADDA0A4-63F4-46E8-9047-F0BA6420C045Q42220109-0475E862-1C6C-4DA2-9701-D49D6D1146DBQ42365101-D1888181-7552-479A-A5F7-FE5F5E4BDAA5Q50720110-A513E603-24A6-4481-9504-2FFED100D0ECQ51105263-4075542B-767E-425E-B38B-34BD31D32763Q54967460-EF26D07C-7D71-4FA0-A07F-71E64291CA89Q58572653-D3094398-4653-4FD9-9497-4FACB623110C
P2860
CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CD133: a potential indicator f ...... s of human cholangiocarcinoma.
@ast
CD133: a potential indicator f ...... s of human cholangiocarcinoma.
@en
type
label
CD133: a potential indicator f ...... s of human cholangiocarcinoma.
@ast
CD133: a potential indicator f ...... s of human cholangiocarcinoma.
@en
prefLabel
CD133: a potential indicator f ...... s of human cholangiocarcinoma.
@ast
CD133: a potential indicator f ...... s of human cholangiocarcinoma.
@en
P2093
P2860
P356
P1433
P1476
CD133: a potential indicator f ...... s of human cholangiocarcinoma.
@en
P2093
Gaosheng Huang
Hongxiang Liu
Qingguo Yan
Yixiong Liu
P2860
P2888
P356
10.1186/1471-2407-11-320
P407
P577
2011-07-29T00:00:00Z
P5875
P6179
1036159970